Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

An Along the Way item Tuesday mistakenly reported that the pair of red crowned cranes at Capron Park Zoo in Attleboro were ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Slashing adverse drug reactions through pharmacogenetics and advanced AI could help rehabilitate the pharmaceutical ...

During a live event, Hans Lee, MD, and participants shared their perspectives on current and upcoming treatment approaches in ...

"Find a secure way to download that data first ... users who want to protect their genetic information before the company completes its sale to Regeneron.

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...

Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm ...

Impax Asset Management significantly reduced its position in Regeneron Pharmaceuticals by 53% in the first quarter, selling 1 ...